HLA B27 Genotyping Reagents
Platform - Taqman probe based genotyping system
Unit - Per sample
Autoimmune disorders like ankylosing spondylitis, and reactive arthritis is progressive in nature. Symptoms typically start in the early 30s but effects are visually seen on an x-ray after many years. The symptoms start out subtle and gradually develop over the years. This test helps determine whether the patient has human leukocyte antigen B27 (HLA-B27) on the surface of his cells and in turn it helps assess the likelihood that he/she may be suffering from an autoimmune disorder.
Min. Requirement -25 Reactions
